Article Text

other Versions

Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?
  1. R Anantharaman
  1. Singleton Hospital, Swansea, United Kingdom
    1. M Heatley
    1. Singleton Hospital, Swansea, United Kingdom
      1. C Weston (c.f.m.weston{at}
      1. Swansea University, United Kingdom


        Patients with acute coronary syndrome (ACS) often have raised blood glucose concentrations when admitted to hospital; a marker for poorer prognosis. Interventions to rapidly normalise blood glucose inconsistently are applied and with uncertain utility. Here we review the association of hyperglycaemia with outcome, present evidence that this hyperglycaemia reflects more than a pre-existing diabetic state and discuss mechanisms by which glucose may adversely affect the course of acute myocardial infarction (AMI). Finally, we seek evidence that intensive insulin treatment improves outcome.

        Statistics from

        Request permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.